HILZINGER KURT J — SEC insider filings
SEC reporting owner CIK 1191504. 41 insider filings on record with FilingPulse; latest filed 2026-10-02.
Transaction summary — filings shown
Covers all 41 filings on record, filed 2020-10-02 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 11 legs across 6 filings — 850,000 shares, $803,022 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 51.
- Largest priced transaction: purchase of 400,000 shares @ $0.44 ($176,520) in Outlook Therapeutics, Inc., filed 2026-05-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | Director | 16 | 11 legs · 850,000 sh · $803,022 | — | 14 |
| HUMANA INC (HUM) | Director | 25 | — | — | 37 |
Insider filings — HILZINGER KURT J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-02 | 4 | HUMANA INC (HUM) | Grant/award (A): 238 (derivative) @ $384.91 | EDGAR |
| 2026-07-02 | 4 | HUMANA INC (HUM) | Grant/award (A): 233 (derivative) @ $392.32 | EDGAR |
| 2026-05-27 | 4 | Outlook Therapeutics, Inc. (OTLK) | Purchase (P): 400,000 @ $0.44 | EDGAR |
| 2026-04-02 | 4 | HUMANA INC (HUM) | Grant/award (A): 536 (derivative) @ $170.66 | EDGAR |
| 2026-01-05 | 4 | HUMANA INC (HUM) | Grant/award (A): 766 (derivative) @ $0 · Grant/award (A): 611 (derivative) @ $258.87 · Grant/award (A): 357 (derivative) @ $258.87 | EDGAR |
| 2025-10-03 | 4 | Outlook Therapeutics, Inc. (OTLK) | Grant/award (A): 286,734 (derivative) @ $0 · Grant/award (A): 90,638 (derivative) @ $0 | EDGAR |
| 2025-10-02 | 4 | HUMANA INC (HUM) | Grant/award (A): 364 (derivative) @ $257.79 | EDGAR |
| 2025-07-02 | 4 | HUMANA INC (HUM) | Grant/award (A): 399 (derivative) @ $242.81 | EDGAR |
| 2025-04-02 | 4 | HUMANA INC (HUM) | Grant/award (A): 345 (derivative) @ $263.88 | EDGAR |
| 2025-01-03 | 4 | HUMANA INC (HUM) | Grant/award (A): 783 (derivative) @ $0 · Grant/award (A): 565 (derivative) @ $254.93 · Grant/award (A): 673 (derivative) @ $254.93 | EDGAR |
| 2024-10-03 | 4 | Outlook Therapeutics, Inc. (OTLK) | Grant/award (A): 56,636 (derivative) @ $0 · Grant/award (A): 105,151 (derivative) @ $0 · Grant/award (A): 18,672 (derivative) @ $0 | EDGAR |
| 2024-10-02 | 4 | HUMANA INC (HUM) | Grant/award (A): 295 (derivative) @ $320.19 | EDGAR |
| 2024-07-02 | 4 | HUMANA INC (HUM) | Grant/award (A): 246 (derivative) @ $379.29 | EDGAR |
| 2024-04-01 | 4 | HUMANA INC (HUM) | Grant/award (A): 270 (derivative) @ $348.41 | EDGAR |
| 2024-03-08 | 4 | Outlook Therapeutics, Inc. (OTLK) | Grant/award (A): 94,441 (derivative) @ $0 | EDGAR |
| 2024-01-03 | 4 | HUMANA INC (HUM) | Grant/award (A): 304 (derivative) @ $456.91 · Grant/award (A): 211 (derivative) @ $456.91 · Grant/award (A): 430 (derivative) @ $0 | EDGAR |
| 2023-10-05 | 4 | Outlook Therapeutics, Inc. (OTLK) | Grant/award (A): 286,670 (derivative) @ $0 | EDGAR |
| 2023-10-03 | 4 | HUMANA INC (HUM) | Grant/award (A): 181 (derivative) @ $490.94 | EDGAR |
| 2023-07-05 | 4 | HUMANA INC (HUM) | Grant/award (A): 215 (derivative) @ $445.24 | EDGAR |
| 2023-04-04 | 4 | HUMANA INC (HUM) | Grant/award (A): 194 (derivative) @ $487.16 | EDGAR |
| 2023-03-31 | 4 | Outlook Therapeutics, Inc. (OTLK) | Grant/award (A): 41,065 (derivative) @ $0 | EDGAR |
| 2023-01-04 | 4 | HUMANA INC (HUM) | Grant/award (A): 205 (derivative) @ $510.30 · Grant/award (A): 185 (derivative) @ $510.30 · Grant/award (A): 380 (derivative) @ $0 | EDGAR |
| 2022-10-07 | 4 | Outlook Therapeutics, Inc. (OTLK) | Grant/award (A): 57,598 (derivative) @ $0 | EDGAR |
| 2022-10-05 | 4 | Outlook Therapeutics, Inc. (OTLK) | Purchase (P): 95,541 @ $1.29 · Purchase (P): 15,662 @ $1.23 | EDGAR |
| 2022-10-04 | 4 | HUMANA INC (HUM) | Grant/award (A): 191 (derivative) @ $492.23 | EDGAR |
| 2022-10-03 | 4 | Outlook Therapeutics, Inc. (OTLK) | Purchase (P): 13,800 @ $1.19 · Purchase (P): 33,199 @ $1.26 · Purchase (P): 41,798 @ $1.25 | EDGAR |
| 2022-07-05 | 4 | HUMANA INC (HUM) | Grant/award (A): 191 (derivative) @ $468.33 | EDGAR |
| 2022-04-04 | 4 | HUMANA INC (HUM) | Grant/award (A): 209 (derivative) @ $440.06 | EDGAR |
| 2022-03-24 | 4 | Outlook Therapeutics, Inc. (OTLK) | Grant/award (A): 21,878 (derivative) @ $0 | EDGAR |
| 2022-03-03 | 4 | Outlook Therapeutics, Inc. (OTLK) | Purchase (P): 27,708 @ $1.69 | EDGAR |
| 2022-02-28 | 4 | Outlook Therapeutics, Inc. (OTLK) | Purchase (P): 41,160 @ $1.46 · Purchase (P): 6,000 @ $1.60 | EDGAR |
| 2022-02-23 | 4 | Outlook Therapeutics, Inc. (OTLK) | Purchase (P): 95,597 @ $1.49 · Purchase (P): 79,535 @ $1.44 | EDGAR |
| 2022-01-04 | 4 | HUMANA INC (HUM) | Grant/award (A): 212 (derivative) @ $465.85 · Grant/award (A): 185 (derivative) @ $465.85 · Grant/award (A): 412 (derivative) @ $0 | EDGAR |
| 2021-10-07 | 4 | Outlook Therapeutics, Inc. (OTLK) | Grant/award (A): 34,425 (derivative) @ $0 | EDGAR |
| 2021-10-04 | 4 | HUMANA INC (HUM) | Grant/award (A): 209 (derivative) @ $394.00 | EDGAR |
| 2021-07-02 | 4 | HUMANA INC (HUM) | Grant/award (A): 194 (derivative) @ $442.71 | EDGAR |
| 2021-04-02 | 4 | HUMANA INC (HUM) | Grant/award (A): 199 (derivative) @ $422.60 | EDGAR |
| 2021-03-26 | 4 | Outlook Therapeutics, Inc. (OTLK) | Grant/award (A): 20,873 (derivative) @ $0 | EDGAR |
| 2021-01-05 | 4 | HUMANA INC (HUM) | Grant/award (A): 227 (derivative) @ $407.15 · Grant/award (A): 218 (derivative) @ $407.15 · Grant/award (A): 403 (derivative) @ $0 | EDGAR |
| 2020-10-05 | 4 | Outlook Therapeutics, Inc. (OTLK) | Grant/award (A): 217,602 (derivative) @ $0 · Grant/award (A): 116,708 (derivative) @ $0.51 | EDGAR |
| 2020-10-02 | 4 | HUMANA INC (HUM) | Grant/award (A): 207 (derivative) @ $410.09 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-02 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1191504 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs